BIOXYTRAN, INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Bioxytran, Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Bioxytran, Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 82.2M shares, a 43% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 82.2M -62.1M -43% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 177M +45.4M +34.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 173M +49.5M +40.1% Mar 31, 2024 10-Q 2024-04-19
Q4 2023 145M +21.3M +17.3% Dec 31, 2023 10-K/A 2025-01-13
Q3 2023 144M +21.3M +17.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 132M +132M Jun 30, 2023 10-Q 2023-07-31
Q1 2023 124M +12.7M +11.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 123M +12.5M +11.3% Dec 31, 2022 10-K/A 2025-01-13
Q3 2022 123M +13.1M +12% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 0 -110M -100% Jun 30, 2022 10-Q 2023-07-31
Q1 2022 111M +10.2M +10.1% Mar 31, 2022 10-Q 2023-05-12
Q4 2021 111M +13.4M +13.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 110M +12.7M +13.1% Sep 30, 2021 10-Q 2021-11-17
Q2 2021 110M +12.8M +13.2% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 101M +12.4M +14.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 97.5M +11M +12.7% Dec 31, 2020 10-K 2022-04-11
Q3 2020 97.2M +11.9M +13.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 97M +11.9M +14% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 88.2M +3.13M +3.68% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 86.5M +1.37M +1.61% Dec 31, 2019 10-K 2021-04-09
Q3 2019 85.3M +203K +0.24% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 85.1M -25.3M -22.9% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 85.1M -20.3M -19.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 85.1M 0 0% Dec 31, 2018 10-K 2020-03-18
Q3 2018 85.1M +50.2M +144% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 110M +75.5M +216% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 105M +81.6M +343% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 85.1M +56.9M +202% Dec 31, 2017 10-K 2019-03-13
Q3 2017 34.9M +3.75M +12% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 34.9M +6.75M +24% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 23.8M -250K -1.04% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 28.2M +15.9M +129% Dec 31, 2016 10-K 2018-04-02
Q3 2016 31.2M +18.9M +153% Sep 30, 2016 10-Q 2016-12-09
Q2 2016 28.2M +15.9M +129% Jun 30, 2016 10-Q/A 2016-09-20
Q1 2016 24.1M +18.3M +314% Mar 31, 2016 10-Q/A 2016-09-20
Q4 2015 12.3M +6.5M +112% Dec 31, 2015 10-K 2017-03-31
Q3 2015 12.3M -279M -95.8% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 12.3M -174M -93.4% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 5.82M -185M -96.9% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 5.82M +1.94M +50% Dec 31, 2014 10-K/A 2016-09-20
Q3 2014 291M +97M +50% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 186M -8.03M -4.14% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 190M +6.99M +3.81% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 3.88M -157M -97.6% Dec 31, 2013 10-K 2015-04-10
Q3 2013 194M +52.8M +37.4% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 194M +65.1M +50.6% Jun 30, 2013 10-Q 2013-08-15
Q1 2013 183M +64.2M +53.9% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 161M +47.4M +41.6% Dec 31, 2012 10-K 2014-04-14
Q3 2012 141M +66.4M +88.8% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 129M +62.6M +94.5% Jun 30, 2012 10-Q/A 2013-01-22
Q1 2012 119M Mar 31, 2012 10-Q/A 2013-01-22
Q4 2011 114M +79.5M +231% Dec 31, 2011 10-K 2013-04-15
Q3 2011 74.7M Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 66.2M Jun 30, 2011 10-Q/A 2012-12-31
Q4 2010 34.4M Dec 31, 2010 10-K/A 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.